Business
Vortex Releases Publication in Nature Scientific
Vortex Releases Publication in Nature Scientific.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 3896E NetScientific PLC 09 February 2018 \n\nPublication in Nature Scientific Reports Describes Potential of Vortex Technology in Personalised Medicine for Lung Cancer patients\n \nLondon, UK - 09 February 2018 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes that its portfolio company, Vortex BioSciences, has announced a report published by Nature Scientific Reports. The peer reviewed report, titled \"Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer\" describes the use of the Vortex's technology in capturing circulating tumour cells (CTCs), in combination with the use of a novel immunofluorescence assay, for measuring programmed cell death ligand 1 (PD-L1) expression on the surface of the CTCs from patients with metastatic non-small cell lung cancer (NSCLC).\n \nThe report can be found online here: https://www.nature.com/articles/s41598-018-19245-w \n \nCommenting on the news, Francois Martelet, Chairman of Vortex BioSciences Inc. and CEO of NetScientific said: \"This report demonstrates the potential clinical utility of circulating tumour cells captured by the Vortex technology in the treatment of lung cancer patients. Recent clinical trials of PD-1 and PD-L1 inhibitors have returned promising clinical responses, providing a rationale for use of the VTX 1 system in personalised medicine.\"\n \n# # #\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott / Jessica Hodgson /\n Chris Welsh / Laura Thornton \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broker)\nJonathan Senior / David Arch / Ben Maddison\n \nVortex Biosciences\nSteve Crouse\n\n\n \nTel: +44 (0) 20 7710 7600\n \n \nTel: +1 (0) 415 823 7649\n [email protected]\n\n\n\n\n \n \nAbout NetScientific \n \nNetScientific is a transatlantic healthcare technology ...